Enzychem Lifesciences Corporation (KOSDAQ:183490)
990.00
-27.00 (-2.65%)
Mar 25, 2026, 7:48 AM KST
Enzychem Lifesciences Market Cap
Enzychem Lifesciences has a market cap or net worth of 76.86 billion as of October 12, 2026. It is the 29,355th most valuable company in the world and the 1,487th biggest in South Korea. Its market cap has decreased by 17.03% in one year.
Market Cap
76.86B
Enterprise Value
-9.90B
Revenue
69.00B
Global Rank
Country Rank
#1,487 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Enzychem Lifesciences's market cap has decreased from 217.47B to 76.86B, a decrease of -64.66%. That is a compound annual growth rate of -10.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 76.86B | -35.29% |
| Dec 30, 2025 | 118.78B | 4.40% |
| Dec 30, 2024 | 113.77B | -26.43% |
| Dec 28, 2023 | 154.65B | 10.86% |
| Dec 29, 2022 | 139.50B | -69.50% |
| Dec 30, 2021 | 457.39B | -47.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 138.74B |
| Kyongbo Pharmaceutical | 129.58B |
| SAMSUNG PHARM. Co., LTD. | 123.77B |
| Dong Sung Bio Pharm.Co.,Ltd. | 117.36B |
| Jeil Pharma Holdings | 116.36B |
| HANDOK | 107.70B |
| CMG Pharmaceutical | 83.25B |
| Kukje Pharma | 79.31B |